Back
PubMed⭐ Featured

Association for Clinical Genomic Science (ACGS) Best Practice Guidelines for Variant Classification in Rare Disease

Durkie M, Cassidy EJ, Owens M, et al. — J Med Genet 2026 · November 2026
Relevance score
7/10
Disease / domain
Rare diseases (variant classification)
Source
PubMed
PMID 43025966

Variant / mechanism

Classification of sequence variants and CNVs, including mitochondrial, non-coding, reduced-penetrance and hypomorphic variants

Summary

A multidisciplinary expert group of the Association for Clinical Genomic Science (ACGS) publishes UK best practice guidelines for variant classification in rare disease, aligned with ACMG and ClinGen frameworks and ratified by ACGS members. They cover sequence variants and CNVs, as well as mitochondrial, non-coding, reduced-penetrance and hypomorphic variants, and incorporate recommendations from the ClinGen Sequence Variant Classification Working Group. The text sets out 25 general recommendations, details each ACMG evidence code and proposes standard report wording; the Bayesian points framework is recommended, with at least two criteria required to classify a variant as (likely) benign or (likely) pathogenic, except for stand-alone benign codes. Variants of uncertain significance are sub-classified by points, and those with limited evidence for pathogenicity that no additional testing could upgrade are not reported. Phenotype specificity is a key criterion, which should not be applied in prenatal testing or newborn screening until phenotypic status is confirmed.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

This text becomes the practical reference for NHS laboratories, but its reach goes beyond the UK: not reporting variants of uncertain significance with no prospect of reclassification and the points framework are clear-cut choices, directly transferable to an exome or genome report. The rule of not applying phenotype specificity in prenatal testing or newborn screening before the phenotype is confirmed deserves to be adopted as is.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 3/3Evidence 2/3Novelty 1/2Sample 0/1Publication 1/1

Clinical impact: 3/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 0/1 · Publication status: 1/1 → Total: 7/10

Keywords

variant classificationACMGvariant of uncertain significanceCNVguidelines
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime